Objective: To compare birth weights in central Sydney to the INTERGROWTH21st international standard to describe current trends in relation to optimal growth and to define areas that may benefit from improved obstetric surveillance and intervention.
INTRODUCTION
Optimal fetal growth is recognised as an essential foundation for both initial survival and long-term health.
1 Poor fetal growth is associated with poorer pregnancy outcomes and has an ongoing impact on infant development and the prevalence of non-communicable adult disease. 2 Small for gestational age (SGA) is often used as proxy for intrauterine growth restriction.
Intrauterine growth restriction is associated with increased rates of stillbirth, increased rates of fetal distress in labour and the development of cerebral palsy in infants. 3, 4 Epidemiological studies that have examined the impact of intrauterine growth restriction on the long-term health of populations have shown increased rates of type II diabetes, hypertension and ischaemic heart disease. At the other end of the growth spectrum, large for gestational age (LGA) or macrosomic infants have increased risk of maternal and fetal morbidity during the intrapartum period, increased rates of neonatal hypoglycaemia and nursery admission and an increased prevalence of obesity, type II diabetes and metabolic syndrome in children. 5 The prevalence of macrosomia in developed countries is between 5% and 20%; however, an increase of 15-25% has been reported in the past two to three decades, likely driven by the global increase in maternal obesity and diabetes. 6 Dysfunctional growth is recognised as being a major public health concern globally and the concept of 'malnutrition' has expanded to include both under-and over-nutrition.
7
Accurate assessment of growth is therefore of major importance and enables both monitoring and timely interventions.
The INTERGROWTH21st project recently developed and published international standards for fetal and newborn growth. 8, 9 The standards are intended to reflect how fetuses and newborns should grow under ideal environmental conditions as opposed to traditional charts describing how they have grown within a particular time period and place. 10 One of the three main studies was the Newborn Cross-Sectional Study (NCSS) which included smoothed centile charts that defined birthweight in male and female infants from 33 to 42 weeks gestation. 
MATERIALS AND METHODS
This was a retrospective analysis of a prospectively collected cohort study which defined risks for early onset pre-eclampsia at the time of women's first routine antenatal visits (11-13 +6 weeks gestation). 
Data collection
An ultrasound was performed and maternal blood collected as part of screening for aneuploidy in the first trimester. The fetal nuchal translucency (NT), fetal heart rate and anatomic survey were completed. Additionally, all women had their height and weight measured (and body mass index (BMI) calculated), blood pressure checked and uterine pulsatility index measured. 
Statistical analysis
Normally distributed data were expressed as means and standard deviations and non-normally distributed continuous data as medians and interquartile ranges (IQRs). For normally distributed data, independent t-tests were performed to compare the means of two groups. The Wilcoxon rank sum test was used to compare distributions for non-normally distributed data. All analyses were performed using SAS software version 9.3 (Cary, NC, USA).
RESULTS
Data regarding maternal history, findings of first trimester screening and delivery outcome were available for 3054 singleton pregnancies. This included 27 women who had a termination of pregnancy after the time of the 11-13 +6 week scan, 14 women who had a miscarriage before 24 weeks gestation and nine women who had an intrauterine death after 24 weeks gestation. Subsequent analysis was restricted to the 3004 women who had a live birth; 38 of these (1.3%) delivered <33 weeks gestation, the earliest gestation at which birthweight centiles were calculated in the INTERGROWTH21st Study. This resulted in a final cohort for analysis of 2966 births.
Prevalence of SGA and LGA infants
The prevalence of SGA and LGA, according to each definition, is shown in Table 1 
Dose response of
LGA with increasing early pregnancy BMI Table 2 demonstrates the increase in proportion of LGA infants with increasing maternal BMI. One in four infants born to obese women were LGA. 
Maternal first trimester characteristics in LGA infants
Descriptive statistics for maternal characteristics and ultrasound findings from the 12 weeks assessment are shown in Table 3 . On univariate analysis, maternal BMI and height were significantly associated with LGA with a mean BMI 1.9 kg/m 2 higher and a mean height 2.9 cm higher for mothers of macrosomic infants.
Caucasian women were more likely to have an LGA infant (78.4% vs 65.5%) and Asian women less likely (19.8% vs 33%). Parity and pre-existing diabetes were also associated with having an LGA infant on univariate analysis. Measurements or investigations from the 12 weeks assessment that were associated with LGA infants were NT, bHCG and PAPP-A multiples of the median.
Multivariate modelling of first trimester risk factors for
LGA at birth Table 4 shows the unadjusted and adjusted odds ratios and con- 
DISCUSSION

Main findings
In a general cohort of pregnant women in Sydney, 16.5% of infants had birthweights >90th percentile using the interna- Data presented as means with standard deviation (SD), medians with interquartile range (IQR) or proportions with %. bHCG, beta human chorionic gonadotropin; BMI, body mass index; BW, body weight; HT, hypertension; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilisation;
LGA, large for gestational age; MoM, multiples of the median; NT, nuchal translucency; MAP, mean arterial pressure; PAPP-A, pregnancy-associated plasma protein A.
Strengths and limitations
The study has a number of strengths. Data was prospectively collected and BMI was measured in early pregnancy rather than self-reported. We have been able to include a quality-assured standardised set of early ultrasound and first trimester screening measurements in a multi-ethnic population. The data is recent,
represents an unselected population of pregnant women rather than a prespecified high-risk group and demonstrates the practical application of the recommended international growth standards. However, it is limited to one health district and not the whole state. We did not assess neonatal morbidity as the study aimed to identify the prevalence of small and large babies and the contributing factors for the greater than expected proportion of large babies. Finally, although this data is relatively recent, it was collected prior to the routine assessment of body composition for all births within our centre and therefore we are unable to analyse any relationship between percentage body fat and the new standard.
Interpretation
It is clear that LGA babies are associated with adverse outcomes for both mother and baby. as a key recommendation necessary to make a long-term effect on the obesity epidemic. 23 Despite recognition of initial delivery complications, estimating fetal weight using ultrasound alone is known to be associated with a 10-15% margin of measurement error. 
CONCLUSIONS
Comparing the international INTERGROWTH21st standards to our population has revealed a markedly high prevalence of LGA infants. The most important modifiable risk factors identified in early pregnancy were maternal BMI and pre-existing diabetes, with higher parity also increasing risk. The most opportune time to address these risk factors is before and between pregnancies. Effective interventions targeting the intergenerational cycle at these time points are going to be essential if we are to make any significant impacts on the obesity epidemic for the next generation.
